SPAC Feed

CALGARY, AB, Aug. 26, 2026 (GLOBE NEWSWIRE) — Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a global leader in SaaS clinical decision support solutions, is pleased to announce, further to its news releases dated June 2, 2026 and July 21, 2026, that it has closed the first tranche (“Tranche 1”) of its previously announced non-brokered private placement of units in the capital of the Company (each, a “Unit”). The Company is also pleased to announce that it has upsized the private placement to up to CDN$1,850,000 and is expected to close the second tranche by September 30, 2026.

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES –

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES –

World of Hurt and Otis College Partner to Reimagine First Aid Through Gen Z Creativity

St. Petersburg, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) — On August 26, 2026, the Raymond James Financial, Inc. (NYSE: RJF) Board of Directors declared a quarterly cash dividend on shares of its common stock of $0.54 per share, payable October 15, 2026 to shareholders of record on October 1, 2026.

AUDUBON, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the acquisition of Higgs Boson Health, a digital healthcare experience company based in Durham, NC and incubated out of Duke University. With a mission to transform healthcare experience through digital innovation, Higgs Boson will position Globus Medical to shape patient and provider experience throughout the full episode of care.

Global Biorisk Management Service Market demand is rising as organizations across Agriculture, Biotechnology, Healthcare, and Pharmaceuticals formalize biosafety governance through consulting, laboratory, monitoring, and risk assessment services. Tightening regulatory documentation requirements, operational incident learning, and technology-enabled assessment accuracy are converging to drive sustained Biorisk Management Service Market growth through 2033. North America currently leads global adoption with approximately 41% market share, supported by stringent regulations and advanced laboratory density. Verified Market Research® projects the Biorisk Management Service Market will expand from USD 2.06 Billion in 2025 to USD 4.91 Billion by 2033, reflecting a Biorisk Management Service Market Forecast CAGR of 11.4%.

Global Biorisk Management Service Market demand is rising as organizations across Agriculture, Biotechnology, Healthcare, and Pharmaceuticals formalize biosafety governance through consulting, laboratory, monitoring, and risk assessment services. Tightening regulatory documentation requirements, operational incident learning, and technology-enabled assessment accuracy are converging to drive sustained Biorisk Management Service Market growth through 2033. North America currently leads global adoption with approximately 41% market share, supported by stringent regulations and advanced laboratory density. Verified Market Research® projects the Biorisk Management Service Market will expand from USD 2.06 Billion in 2025 to USD 4.91 Billion by 2033, reflecting a Biorisk Management Service Market Forecast CAGR of 11.4%.

APPOINTS TIM LEDWICK AS CHIEF FINANCIAL OFFICER AND CHRISTOPHER DEVALL AS CHIEF OPERATING OFFICER

PARSIPPANY, NJ, Aug. 26, 2026 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (OTCID: IDXG) (“Interpace” or the “Company”), an emerging leader in enabling personalized medicine, today announced that it will effect a 1-for-5 reverse stock split (“Reverse Stock Split”) of its issued and outstanding common stock. The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on August 27, 2026, and Interpace common stock is expected to begin trading on a split-adjusted basis on the OTCID quotation system (“OTCID”) as of the commencement of market open that same day. Interpace’s ticker symbol on the OTCID will temporarily change to IDXGD for a period of 20 trading days, including the effective date. The new CUSIP number for the common stock following the Reverse Stock Split will be 46062X402.

Seeking Greatness Reports More Than PLN 30 Million in Sales Over Four Years

Washington, D.C., Aug. 26, 2026 (GLOBE NEWSWIRE) —

New Study Finds Huge Leap in Afterschool Programs Providing STEM Education,

2026 Connectivity Report reveals submission automation, not commission, is now driving where agents place business

2026 Connectivity Report reveals submission automation, not commission, is now driving where agents place business

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

New York paper goods brand introduces large-format colored art paper and curated multi-color sketching pads for working artists

New York paper goods brand introduces large-format colored art paper and curated multi-color sketching pads for working artists

Nanterre, 26 August 2026

Nanterre, le 26 août 2026

Read manuals online for free, upload photos of product problems and get help from AI or real users in 164 languages

Read manuals online for free, upload photos of product problems and get help from AI or real users in 164 languages

The multiple system atrophy clinical trial analysis report delivers important insights into ongoing research of 24+ pipeline multiple system atrophy drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

The multiple system atrophy clinical trial analysis report delivers important insights into ongoing research of 24+ pipeline multiple system atrophy drugs, clinical strategies, upcoming therapeutics, and commercial analysis.